{"brief_title": "BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery", "brief_summary": "The purpose of this study is to learn if BMS-562247 can prevent blood clots in the legs and lungs in men and women following unilateral total knee replacement surgery. The safety of this treatment will also be studied.", "condition": "Pulmonary Embolism", "intervention_type": "Drug", "intervention_name": "Apixaban Placebo", "description": "Tablets, Oral, BID, 12 +/- 2 days", "arm_group_label": "E1", "other_name": "BMS-562247", "criteria": "Inclusion Criteria: - Undergoing elective unilateral total knee replacement surgery. - Willing and able to undergo bilateral ascending contrast venography. - Able to inject (by self or caregiver) study medication subcutaneously. Exclusion Criteria: - Women of childbearing potential. - Women who are pregnant or breastfeeding. - Under some conditions, subjects weighing more than 300 lbs. (136kg) and/or Body Mass Index (BMI) >=35 kg/m2", "gender": "All", "minimum_age": "18 Years", "maximum_age": "90 Years", "healthy_volunteers": "No", "id": "NCT00097357.xml"}